Cleared Traditional

K071934 - MARROWSTIM CONCENTRATION KIT AND MARROWSTIM MINI CONCENTRATION KIT

K071934 is an FDA 510(k) clearance for MARROWSTIM CONCENTRATION KIT AND MARROW..., manufactured by Biomet Manufacturing Corp. The device is a Class 1 Hematology device with product code JQC cleared through the Traditional 510(k) pathway after a 90-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2007
Decision
90d
Days
Class 1
Risk

K071934 is an FDA 510(k) clearance for the MARROWSTIM CONCENTRATION KIT AND MARROWSTIM MINI CONCENTRATION KIT. Classified as Centrifuges (micro, Ultra, Refrigerated) For Clinical Use (product code JQC), Class I - General Controls.

Submitted by Biomet Manufacturing Corp (Warsaw, US). The FDA issued a Cleared decision on October 11, 2007 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 862.2050 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K071934

510(k) Number K071934 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 2007
Decision Date October 11, 2007
Days to Decision 90 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 113d · This submission: 90d
Pathway characteristics
Predicate-based equivalence.

JQC Device Classification - Class 1, General Controls

Product Code JQC Centrifuges (micro, Ultra, Refrigerated) For Clinical Use
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.2050
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JQC Centrifuges (micro, Ultra, Refrigerated) For Clinical Use

All 37
Devices cleared under the same product code (JQC) and FDA review panel - the closest regulatory comparables to K071934.
PureBMC SupraPhysiologic Concentrating System 30 mL System, PureBMC SupraPhysiologic Concentrating System 60 mL System, PureBMC SupraPhysiologic Concentrating System 120 mL System
K183205 · Emcyte Corporation · May 2019
SMARTPREP2 BMAC SYSTEM, SMARTPREP PLATELET CONCENTRATION SYSTEM
K103340 · Harvest Technologies, Corp. · Dec 2010
AXP PLATFORM MARROW XPRESS SYSTEM MODEL 8-5137, 8-5138, 8-5139, 8-5140 (PRIMARY)
K081345 · Thermogenesis Corp. · Jul 2008
GENESISCS COMPONENT CONCENTRATING SYSTEM
K070666 · Perfusion Partners & Assoc., Inc. · Jun 2007
SMARTPREP2 CENTRIFUGE SYSTEM
K052925 · Harvest Technologies, Corp. · Jan 2006
COBE ANGEL WHOLE BLOOD SEPARATION SYSTEM
K042473 · Cobe Cardiovascular, Inc. · Nov 2004